“Mr. Jobs suffers from immune system issues common with people who have received liver transplants and, as a result, his health suffers from frequent ‘ups and downs,’ according to a person with knowledge of the situation, who agreed to speak on condition of anonymity because he was not authorized to discuss it,” Helft reports. “In recent weeks, Mr. Jobs began a down cycle and slowed his activities at Apple, the person said. Mr. Jobs has been coming to the office about two days a week, and appeared increasingly emaciated, the person said. He frequently lunched in his office, rather than in the company cafeteria, the person said.”
Helft reports, “Analysts said that many investors might wonder whether Mr. Jobs will come back to Apple at all, and trade accordingly. ‘It is natural that investors will expect the worse,’ said Charles Wolf, an analyst with Needham & Company, noting that Apple has a history of ‘minimal disclosure” and “obfuscating’ details about Mr. Jobs’s health. Mr. Wolf said that regardless of whether Mr. Jobs returns to Apple, the company would probably continue doing well for the foreseeable future, though its long-term prospects are a matter of speculation. ‘Right now Apple has a management team that is one of the greatest in American business,’ Mr. Wolf said. ‘Whatever trajectory the company is on will continue for two to five years, regardless of whether Steve comes back.'”
Full article here.